Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 25.


Curley, Paul ORCID: 0000-0003-4596-2708, Liptrott, Neill J ORCID: 0000-0002-5980-8966 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) Advances in nanomedicine drug delivery applications for HIV therapy. FUTURE SCIENCE OA, 4 (1). FSO230-.


Hobson, James J ORCID: 0000-0003-2551-1774, Curley, Paul ORCID: 0000-0003-4596-2708, Savage, Alison C ORCID: 0000-0002-5312-9946, Al-khouja, Amer, Siccardi, Marco ORCID: 0000-0002-3539-7867, Flexner, Charles, Meyers, Caren Freel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Rannard, Steve P ORCID: 0000-0002-6946-1097
(2019) Anhydrous nanoprecipitation for the preparation of nanodispersions of tenofovir disoproxil fumarate in oils as candidate long-acting injectable depot formulations. NANOSCALE ADVANCES, 1 (11). pp. 4301-4307.


Gallardo-Toledo, Eduardo ORCID: 0009-0000-8534-9030, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne ORCID: 0000-0001-8482-5736, Herriott, Joanne, Kijak, Edyta, Bramwell, Chloe ORCID: 0000-0001-8274-457X, Curley, Paul ORCID: 0000-0003-4596-2708, Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712
et al (show 6 more authors) (2023) Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses, 15 (11). 2161-.


Curley, Paul ORCID: 0000-0003-4596-2708, Siccardi, Marco ORCID: 0000-0002-3539-7867, Moss, Darren M and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Development and validation of an LC-MS/MS assay for the quantification of efavirenz in different biological matrices. BIOANALYSIS, 8 (20). pp. 2125-2134.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 13 more authors) (2021) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (4). pp. 2078-2088.


Rajoli, Rajith Kr ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 13 more authors) (2020) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. medRxiv : the preprint server for health sciences.


Curley, Paul ORCID: 0000-0003-4596-2708, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Moss, Darren M, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Letendre, Scott, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2017) Efavirenz Is Predicted To Accumulate in Brain Tissue: an <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> Investigation. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (1). e01841-e01816.


Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Gallardo-Toledo, Eduardo, Herriott, Joanne, Kijak, Edyta, Bramwell, Chloe, Cox, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Box, Helen, Curley, Paul ORCID: 0000-0003-4596-2708
et al (show 11 more authors) (2023) Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters. VIRUSES-BASEL, 15 (8). 1744-.


Brevini, Teresa, Maes, Mailis, Webb, Gwilym J, John, Binu V, Fuchs, Claudia D, Buescher, Gustav, Wang, Lu, Griffiths, Chelsea, Brown, Marnie L, Scott, William EIII
et al (show 69 more authors) (2023) FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. NATURE, 615 (7950). 134-+.


Curley, Paul ORCID: 0000-0003-4596-2708, Giardiello, Marco ORCID: 0000-0003-0560-4711, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Dickens, David ORCID: 0000-0001-8295-0752, Moss, Darren M, Hobson, James J ORCID: 0000-0003-2551-1774, Savage, Alison C, McDonald, Tom O, Siccardi, Marco, Rannard, Steve
et al (show 1 more authors) (2017) In vitro characterisation of solid drug nanoparticle compositions of efavirenz in a brain endothelium cell line. Journal of Interdisciplinary Nanomedicine, 2 (3). pp. 157-169.


Box, Helen J, Sharp, Joanne, Pennington, Shaun H, Kijak, Edyta, Tatham, Lee ORCID: 0000-0001-9448-8876, Caygill, Claire H, Lopeman, Rose C, Jeffreys, Laura N, Herriott, Joanne, Neary, Megan
et al (show 15 more authors) (2023) Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters. The Journal of antimicrobial chemotherapy, 79 (1). dkad362-dkad362.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Valentijn, Anthony, Hobson, James ORCID: 0000-0003-2551-1774, Unsworth, Catherine
et al (show 6 more authors) (2021) Optimisation and validation of a sensitive bioanalytical method for niclosamide. [Preprint]


Curley, Paul, Hobson, James J ORCID: 0000-0003-2551-1774, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Makarov, Edward, Al-Khouja, Amer, Tatham, Lee ORCID: 0000-0001-9448-8876, David, Christopher AW ORCID: 0000-0001-8504-2354, Box, Helen, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne
et al (show 7 more authors) (2023) Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics, 15 (7). p. 1835.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Chiong, Justin ORCID: 0000-0001-8063-6399, Back, David, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2019) Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. JOURNAL OF INFECTIOUS DISEASES, 219 (11). pp. 1735-1742.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Rajoli, Rajith Kr ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 12 more authors) (2020) Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. Clinical pharmacology and therapeutics, 108 (4). pp. 775-790.


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan, Sharp, Joanne, Liptrott, Neill ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 11 more authors) (2020) Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics. Clinical Pharmacology and Therapeutics.


Neary, Megan ORCID: 0000-0002-4960-2139, Arshad, Usman ORCID: 0000-0003-1586-1885, Tatham, Lee ORCID: 0000-0001-9448-8876, Pertinez, Henry, Box, Helen, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Valentijn, Anthony, Sharp, Joanne, Rannard, Steve ORCID: 0000-0002-6946-1097, Biagini, Giancarlo ORCID: 0000-0001-6356-6595
et al (show 2 more authors) (2021) Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. [Preprint]


Neary, Megan ORCID: 0000-0002-4960-2139, Arshad, Usman ORCID: 0000-0003-1586-1885, Tatham, Lee ORCID: 0000-0001-9448-8876, Pertinez, Henry, Box, Helen, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Valentijn, Anthony, Sharp, Joanne, Rannard, Steve P ORCID: 0000-0002-6946-1097, Biagini, Giancarlo A
et al (show 2 more authors) (2023) Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1228. 123823-.


Hobson, James ORCID: 0000-0003-2551-1774, Savage, Alison, Dwyer, Andrew, Unsworth, Catherine, Arshad, Usman, Pertinez, Henry, box, helen, Tatham, Lee, Rajoli, Rajith ORCID: 0000-0002-6015-5712, Neary, Megan ORCID: 0000-0002-4960-2139
et al (show 8 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Unknown.


Hobson, James Joseph ORCID: 0000-0003-2551-1774, Savage, Alison Clare ORCID: 0000-0002-5312-9946, Dwyer, Andrew, Unsworth, Catherine, Massam, Jonathan, Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee M ORCID: 0000-0001-9448-8876, Rajoli, Rajith ORCID: 0000-0002-6015-5712
et al (show 9 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Nanoscale, 13 (13). pp. 6410-6416.


Hobson, James ORCID: 0000-0003-2551-1774, Savage, Alison, Dwyer, Andrew, Unsworth, Catherine, Arshad, Usman, Pertinez, Henry, box, helen, Tatham, Lee, Rajoli, Rajith KR, Neary, Megan
et al (show 8 more authors) (2021) Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection.


Hobson, James ORCID: 0000-0003-2551-1774, Al-Khouja, Amer, Curley, Paul ORCID: 0000-0003-4596-2708, Meyers, David, Flexner, Charles, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651, Freel Meyers, Caren and Rannard, SP ORCID: 0000-0002-6946-1097
(2019) Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies. Nature Communications, 10.


Siccardi, Marco ORCID: 0000-0002-3539-7867, Martin, Phillip, Smith, Darren ORCID: 0000-0003-4925-467X, Curley, Paul ORCID: 0000-0003-4596-2708, McDonald, Tom, Giardiello, Marco ORCID: 0000-0003-0560-4711, Liptrott, Neill ORCID: 0000-0002-5980-8966, Rannard, Steve ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Towards a rational design of solid drug nanoparticles with optimised pharmacological properties. Journal of interdisciplinary nanomedicine, 1 (3). pp. 110-123.


Curley, Paul ORCID: 0000-0003-4596-2708
(2015) Understanding disposition of efavirenz and application in solid drug nanoparticle development. PhD thesis, University of Liverpool.


Moss, Darren Michael, Curley, Paul ORCID: 0000-0003-4596-2708, Kinvig, Hannah ORCID: 0000-0002-0061-1683, Hoskins, Clare and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018) The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 12 (3). pp. 223-236.

This list was generated on Mon Feb 12 10:33:11 2024 GMT.